Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104031063A reveals novel cyanation route for high-purity quinolone intermediates enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN106282135A details a robust RrQR enzyme process for (R)-3-quinuclidinol, offering superior stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114317472B details a novel biocatalytic route for (S)-nornicotine using immobilized imine reductase, offering superior purity and scalable manufacturing for pharmaceutical intermediates.
Novel patent CN107698523A offers high-yield Gefitinib preparation with reduced pollution and cost advantages for supply chain stability.
Patent CN113651864A reveals a safer synthesis route for Diquafosol Tetrasodium using inorganic ammonia, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
This patent details a novel biocatalytic route for sitagliptin intermediates offering high purity and yield. It enables significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN114045271B reveals high-efficiency biocatalysis for Atazanavir intermediates. Discover cost reduction and supply chain reliability with immobilized enzyme technology.
Discover a green synthesis method for Cefodizime Sodium replacing toxic catalysts. Achieve >99.7% purity and significant cost reduction in pharmaceutical manufacturing.
Patent CN113652408A reveals a novel carbonyl reductase mutant for efficient (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering superior yield and green manufacturing advantages.
Patent CN112481320B details a novel recombinant lactamase for producing optically pure (-)-γ-lactam. This breakthrough offers superior stability and stereoselectivity for antiviral drug synthesis.
Patent CN111057735B details a novel esterase route for high-purity chiral intermediates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN110981800A reveals a novel low-temperature route for Lenvatinib intermediates using ZnO catalysis, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Novel rhodium-catalyzed route ensures high purity intermediate for Suvorexant. Reduces toxicity and simplifies supply chain for global pharmaceutical manufacturing partners.
Novel synthesis of 4-trifluoromethylsulfanyl aniline via anhydrous HF fluorination. Cost-effective route for green veterinary drug intermediates with high purity.
Novel Rh-catalyzed synthesis offers high purity and cost reduction for Suvorexant intermediate manufacturing supply chain. This patent data reveals significant process improvements for reliable pharmaceutical intermediates supplier partnerships.
Patent CN109182298A reveals high-efficiency CALB mutants for chiral intermediate synthesis, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel patent CN108218753A details efficient synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN106966901B enables green synthesis of lipoic acid intermediates with boron recycling. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103998618A reveals enzymatic hydrolysis for high-purity chiral intermediates. Discover supply chain advantages and cost reduction strategies.
Patent CN104178469B reveals high-purity enzymatic route for Cilastatin intermediate. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.